The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians

Clinical Immunology

Volumn 148, Issue 2, 2013, Pages 206-208

  Maier Moore, Jacen S ^a,b   Cañas, Carlos A ^c   Tobón, Gabriel ^c   Arango, Alvaro ^d   Anaya, Juan Manuel ^e   Scofield, R Hal ^a,b,f  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSIDAD ICESI   (Colombia)

^d Clinica Universitaria Bolivariana   (Colombia)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CCR5 delta 32; Rs333; Sj gren's syndrome; Type 1 Diabetes

Indexed keywords

CHEMOKINE RECEPTOR CCR5; DNA;

CELL MIGRATION; CELL SURFACE; COLOMBIA; DNA POLYMORPHISM; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; LEUKOCYTE; PRIORITY JOURNAL; SJOEGREN SYNDROME;

CCR5 DELTA 32; RS333; SJÖGREN'S SYNDROME; TYPE 1 DIABETES;

COLOMBIA; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; SJOGREN'S SYNDROME;

EID: 84879294948     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.05.010     Document Type: Letter

References (10)

1. Jacobsson L., Hansen B.U., Manthorpe R., Hardgrave K., Neas B., Harley J.B. Association of dry eyes and dry mouth with anti-Ro/SS-A and anti-La/SS-B autoantibodies in normal adults. Arthritis Rheum. 1992, 35:1492-1501.
2. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464 (2010) 1293-300.
3. Pfleger C., Kaas A., Hansen L., Alizadeh B., Hougaard P., et al. Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes. Clin. Immunol. 2008, 128:57-65.
4. Gulati A., Sacchetti M., Bonini S., Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch. Ophthalmol. 2006, 124:710-716.
5. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
6. Zoja C., Donadelli R., Colleoni S., Figliuzzi M., Bonazzola S., et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int. 1998, 53:1608-1615.
7. Petrek M., Cermakova Z., Hutyrova B., Micekova D., Drabek J., et al. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin. Exp. Rheumatol. 2002, 20:701-703.
8. Muntinghe F.L., Gross S., Bakker S.J., Landman G.W., van der Harst P., et al. CCR5Delta32 genotype is associated with outcome in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 2009, 86:140-145.
9. Stephens J.C., Reich D.E., Goldstein D.B., Shin H.D., Smith M.W., et al. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet. 1998, 62:1507-1515.
10. McNicholl J.M., Smith D.K., Qari S.H., Hodge T. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele. Emerg. Infect. Dis. 1997, 3:261-271.